ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES-Reference-Cited by-同舟云学术

ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES

Published:2005-04-15 Issue:7 Volume:33 Page:993-1003
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Noreault Trisha L.,Kostrubsky Vsevolod E.,Wood Sheryl G.,Nichols Ralph C.,Strom Stephen C.,Trask Heidi W.,Wrighton Steven A.,Evans Ronald M.,Jacobs Judith M.,Sinclair Peter R.,Sinclair Jacqueline F.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference55 articles.

1. Effects of arsenite on hepatic mixed-function oxidase activity in rats

2. Interleukin 1? inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance

3. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction

4. MECHANISMS OF ARSENITE-MEDIATED DECREASES IN BENZO[K]FLUORANTHENE-INDUCED HUMAN CYTOCHROME P4501A1 LEVELS IN HEPG2 CELLS

5. SXR, a novel steroid and xenobioticsensing nuclear receptor

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in drug resistance of osteosarcoma caused by pregnane X receptor;Drug Metabolism Reviews;2024-06-13

2. Differential modulation of cytochrome P450 enzymes by arsenicals in non-human experimental models;Drug Metabolism Reviews;2023-09-07

3. Evaluation of oxidative stress-mediated cytotoxicity and genotoxicity of copper and flubendiamide: amelioration by antioxidants in vivo and in vitro;Toxicology Research;2023-03-07

4. Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer;International Journal of Molecular Sciences;2022-09-19

5. ARSENIC: VARIOUS SPECIES WITH DIFFERENT EFFECTS ON CYTOCHROME P450 REGULATION IN HUMANS;EXCLI J;2021